NEW YORK, May 19 (UPI) --Finding and treating people with undiagnosed asthma or chronic obstructive pulmonary disease improved their health and led to fewer appointments for respiratory symptoms in ...

Researchers report that as many as 70% of people with chronic obstructive pulmonary disease (COPD) or asthma could be undiagnosed. They say that receiving a diagnosis and treatment can dramatically ...

Asthma and chronic obstructive pulmonary disease (COPD) are chronic respiratory diseases that cause breathing difficulty and coughing. Both conditions share similar symptoms. Understanding their ...

Dr. Shawn Aaron, a senior scientist and lung specialist at The Ottawa Hospital and professor at the University of Ottawa. Finding and treating people with undiagnosed asthma or chronic obstructive ...

Mepolizumab significantly reduces exacerbations in patients with asthma and concurrent chronic obstructive pulmonary disease (COPD), with a 55% reduction in COPD exacerbations post initiation. A ...

Current drug treatments have been incorporated into clinical practice guidelines, such as the NAEPP EPR-3 for asthma [101] and GOLD treatment guidelines for COPD, [102] both of which recognize the ...

Lindsay Curtis is a health & medical writer in South Florida. She worked as a communications professional for health nonprofits and the University of Toronto’s Faculty of Medicine and Faculty of ...

Bronchiectasis hospitalizations have higher mortality and costs than COPD and asthma, with a median stay of 5 days and costs of $50,393. During the COVID-19 pandemic, bronchiectasis hospitalizations ...

Please provide your email address to receive an email when new articles are posted on . Length of stay was 1 day longer for those with asthma-COPD overlap vs. COPD or asthma alone and the cost was ...